Antiviral activity of diarylheptanoid stereoisomers against respiratory syncytial virus in vitro and in vivo

Journal of Natural Medicines

Volumn 67, Issue 4, 2013, Pages 773-781

  Konno, Katsuhiko ^a   Miura, Motofumi ^b   Toriyama, Masaharu ^b   Motohashi, Shigeyasu ^b   Sawamura, Rie ^a   Watanabe, Wataru ^a   Yoshida, Hiroki ^a   Kato, Masahiko ^a   Yamamoto, Ryuichi ^a   Yasukawa, Ken ^b   Kurokawa, Masahiko ^a  

^a KYUSHU UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^b NIHON UNIVERSITY   (Japan)

Author keywords

Alpinia officinarum; Antiviral; Diarylheptanoid; RSV; Stereoisomer; Synthesis of diarylheptanoids

Indexed keywords

5 HYDROXY 7 (4 HYDROXYPHENYL) 1 PHENYLHEPT 3 ONE; 5 HYDROXY 7 (4'' HYDROXYPHENYL) 1 PHENYLHEPT 3 ONE; 5 METHOXY 1,7 DIPHENYLHEPT 3 ONE; ANTIVIRUS AGENT; AO 0011; AO 0503; AO 0504; AO 0514; GAMMA INTERFERON; HEPTANE DERIVATIVE; RIBAVIRIN; UNCLASSIFIED DRUG;

ALPINIA OFFICINARUM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CARCINOMA CELL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG ISOLATION; DRUG STRUCTURE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG LAVAGE; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; RACEMIC MIXTURE; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS INFECTION; STEREOISOMERISM; TREATMENT OUTCOME; VIRUS PNEUMONIA; VIRUS TITRATION;

ALPINIA; ANIMALS; ANTIVIRAL AGENTS; CELL LINE, TUMOR; DIARYLHEPTANOIDS; FEMALE; HUMANS; INTERFERON-GAMMA; LUNG; MICE; MICE, INBRED BALB C; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; STEREOISOMERISM;

EID: 84884202958     PISSN: 13403443     EISSN: 18610293     Source Type: Journal    
DOI: 10.1007/s11418-013-0743-6     Document Type: Article

References (34)

1. Leader S, Kohlhase K (2003) Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000. J Pediatrics 143:127-132
2. Chi H, Chang IS, Tsai FY, Huang LM, Shao PL, Chiu NC, Chang LY, Huang FY (2011) Epidemiological study of hospitalization associated with respiratory syncytial virus infection in Taiwanese children between 2004 and 2007. J Form Med Assoc 110:388-396
3. Rodríguez-Auad JP, Nava-Frías M, Casasola-Flores J, Johnson KM, Nava-Ruiz A, Pérez-Robles V, Caniza MA (2012) The epidemiology and clinical characteristics of respiratory syncytial virus infection in children at a public pediatric referral hospital in Mexico. Int J Inf Dis 16:508-513
4. Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE (2005) Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med 352:1749-1759
5. Villarruel GR, Langley GE, Abedi GR, Anderson LJ (2010) Respiratory syncytial virus activity - United States, July 2008-December 2009. MMWR Morb Mortal Wkly Rep 59:230-233
6. Shah JN, Chemaly RF (2011) Management of RSV infections in adult recipients of hematopoietic stem cell transplantation. Blood 117:2755-2763
7. Weisman LE (2009) Respiratory syncytial virus (RSV) prevention and treatment: past, present, and future. Cardiovasc Hematol Agents Med Chem 7:223-233
8. Pelaez A, Lyon GM, Force SD, Ramirez AM, Neujahr DC, Foster M, Naik PM, Gal AA, Mitchell PO, Lawrence EC (2009) Efficacy of oral ribavirin in lung transplant patients with respiratory syncytial virus lower respiratory tract infection. J Heart Lung Transpl 28:67-71
9. Cingoz O (2009) Motavizumab. MAbs 1:439-442
10. Gill MA, Welliver RC (2009) Motavizumab for the prevention of respiratory syncytial virus infection in infants. Expert Opin Biol Ther 9:1335-1345
11. Fernández P, Trenholme A, Abarca K, Griffin MP, Hultquist M, Harris B, Losonsky GA (2010) A phase 2, randomized, double-blind safety and pharmacokinetic assessment of respiratory syncytial virus (RSV) prophylaxis with motavizmab and palivizumab administered in the same season. BMC Pediatrics 10:38
12. Zamora MR, Budev M, Rolfe M, Gottlieb J, Humar A, Devincenzo J, Vaishnaw A, Cehelsky J, Albert G, Nochur S, Gollob JA, Glanville AR (2011) RNA interference therapy in lung transplant patients infected with respiratory syncytial virus. Am J Respir Crit Care Med 183:531-538
13. Rouan MC, Gevers T, Roymans D, de Zwart L, Nauwelaers D, De Meulder M, van Remoortere P, Vanstockem M, Koul A, Simmen K, Andries K (2010) Pharmacokinetics-pharmacodynamics of a respiratory syncytial virus fusion inhibitor in the cotton rat model. Antimicrob Agents Chemother 54:4534-4539
14. Chapman J, Abbott E, Alber DG, Baxter RC, Bithell SK, Henderson EA, Carter MC, Chambers P, Chubb A, Cockerill GS, Collins PL, Dowdell VC, Keegan SJ, Kelsey RD, Lockyer MJ, Luongo C, Najarro P, Pickles RJ, Simmonds M, Taylor D, Tyms S, Wilson LJ, Powell KL (2007) RSV604, a novel inhibitor of respiratory syncytial virus replication. Antimicrob Agents Chemother 51:3346-3353
15. Yasukawa K, Sun Y, Kitanaka S, Tomizawa N, Miura M, Motohashi S (2008) Inhibitory effect of the rhizomes of Alpinia officinarum on TPA-induced inflammation and tumor promotion in two-stage carcinogenesis in mouse skin. J Nat Med 62:374-378
16. Tabata K, Yamazaki Y, Okada M, Fukumura K, Shimada A, Sun Y, Yasukawa K, Suzuki T (2009) Diarylheptanoids derived from Alpinia officinarum induce apoptosis, S-phase arrest and differentiation in human neuroblastoma cells. Anticancer Res 29:4981-4988
17. Lee J, Kim KA, Jeong S, Lee S, Park HJ, Kim NJ, Lim S (2009) Anti-inflammatory, anti-nociceptive, and anti-psychiatric effects by the rhizomes of Alpinia officinarum on complete Freund's adjuvant-induced arthritis in rats. J Ethnopharmacol 126:258-264
18. Ly TN, Shimoyamada M, Kato K, Yamauchi R (2003) Isolation and characterization of some antioxidative compounds from the rhizomes of smaller galanga (Alpinia officinarum Hance). J Agric Food Chem 51:4924-4929
19. Ly TN, Shimoyamada M, Kato K, Yamauchi R (2004) Antioxidative compounds isolated from the rhizomes of smaller galanga (Alpinia officinarum Hance). BioFactors 21:305-308
20. Matsuda H, Nakashima S, Oda Y, Nakamura S, Yoshikawa M (2009) Melanogenesis inhibitors from the rhizomes of Alpinia officinarum in B16 melanoma cells. Bioorg Med Chem 17:6048-6053
21. Sawamura R, Sun Y, Yasukawa K, Shimizu T, Watanabe W, Kurokawa M (2010) Antiviral activities of diarylheptanoids against influenza virus in vitro. J Nat Med 64:117-120
22. Konno K, Sawamura R, Sun Y, Yasukawa K, Shimizu T, Watanabe W, Kato M, Yamamoto R, Kurokawa M (2011) Antiviral activities of diarylheptanoids isolated from Alpinia officinarum against respiratory syncytial virus, poliovirus, measles virus, and herpes simplex virus type 1 in vitro. Nat Prod Commun 6:1881-1884
23. Watanabe W, Shimizu T, Hino A, Kurokawa M (2008) A new assay system for evaluation of developmental immunotoxicity of chemical compounds using respiratory syncytial virus infection to offspring mice. Environ Toxicol Pharmacol 25:69-74
24. Watanabe W, Konno K, Ijichi K, Inoue H, Yokota T, Shigeta S (1994) MTT colorimetric assay system for the screening of anti-orthomyxo- and anti-paramyxoviral agents. J Virol Methods 48:257-265
25. Watanabe W, Shimizu T, Hino A, Kurokawa M (2008) Effects of decabrominated diphenyl ether (DBDE) on developmental immunotoxicity in offspring mice. Environ Toxicol Pharmacol 26:315-319
26. Sawamura R, Shimizu T, Sun Y, Yasukawa K, Miura M, Toriyama M, Motohashi S, Watanabe W, Konno K, Kurokawa M (2010) In vitro and in vivo anti-influenza virus activity of diarylheptanoids isolated from Alpinia officinarum. Antivir Chem Chemother 21:33-41
27. Gemal LA, Luche LJ (1981) Lanthanoids in organic synthesis. 6. The reduction of α-enones by sodium borohydride in the presence of lanthanoid chlorides: synthetic and mechanistic aspects. J Am Chem Soc 103:5454-5459
28. Katsuki T, Sharpless KB (1980) The first practical method for asymmetric epoxidation. J Am Chem Soc 102:5974-5976
29. Xie YY, Zhao XD, Jiang LP, Liu HL, Wang LJ, Fang P, Shen KL, Xie ZD, Wu YP, Yang XQ (2006) Inhibition of respiratory syncytial virus in cultured cells by nucleocapsid gene targeted deoxyribozyme (DNAzyme). Antiviral Res 71:31-41
30. Kawana F, Shigeta S, Hosoya M, Suzuki H, De Clercq E (1978) Inhibitory effects of antiviral compounds on respiratory syncytial virus replication in vitro. Antimicrob Agents Chemother 31:1225-1230
31. Watanabe W, Shimizu T, Sawamura R, Hino A, Konno K, Hirose A, Kurokawa M (2010) Effects of tetrabromobisphenol A, a brominated flame retardant, on the immune response to respiratory syncytial virus infection in mice. Int Immunopharmacol 10:393-397
32. Comin MJ, Vu BC, Boyer PL, Liao C, Hughes SH, Marquez VE (2008) D-(+)-iso-methanocarbathymidine: a high-affinity substrate for herpes simplex virus 1 thymidine kinase. ChemMedChem 3:1129-1134
33. Barber-Rotenberg JS, Selvarnathran SP, Kong Y, Erkizan HV, Snyder TM, Hong SP, Kobs CL, South NL, Summer S, Monroe PJ, Chruszcz M, Dobrev V, Tosso PN, Scher LJ, Minor W, Brown ML, Metallo SJ, Üren A, Toretsky JA (2012) Single enantiomer of YK-4-279 demonstrates specificity in targeting the oncogene EWS-FLI1. Oncotarget 3:172-182
34. Burgess JA, Stevens CW, Fahl WE (1985) Mutation at separate gene loci in Salmonella typhimurium TA100 related to DNA nucleotide modification by stereoisomeric benzo(a)pyrene 7,8-diol-9,10-epoxides. Cancer Res 45:4257-4262